Results 201 to 207 of about 4,006,149 (207)

Advances in the discovery and development of selective heme-displacing IDO1 inhibitors

Expert Opinion on Drug Discovery, 2020
Lijun Sun
exaly  

Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma.

, 2018
C. Slingluff, S. Fling, I. Mauldin, M. Ernstoff, B. Hanks, K. Delman, D. Lawson, B. Gastman, J. Kaiser, M. Cheever   +9 more
semanticscholar   +1 more source

Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?

Annual Review of Cancer Biology, 2020
Benoit van den Eynde, Jean-François Baurain   +1 more
exaly  

Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor

Bioorganic Chemistry, 2020
exaly  

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors

Frontiers in Pharmacology, 2020
Yuwei Wang, Xiao Jun Yao, Yue-Ming Li
exaly  

Potential Underprediction of Warfarin Drug Interaction From Conventional Interaction Studies and Risk Mitigation: A Case Study With Epacadostat, an IDO1 Inhibitor

Journal of clinical pharmacology, 2016
Jack Shi, Xuejun Chen, Naresh Punwani, W. Williams, S. Yeleswaram   +4 more
semanticscholar   +1 more source

4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors

Bioorganic and Medicinal Chemistry, 2019
Zhouyu Wang, Fei Wang, Shan Qian
exaly